MediWound (MDWD) Asset Utilization Ratio (2016 - 2025)
MediWound (MDWD) recorded quarterly Asset Utilization Ratio of 0.17 in Q4 2025, down 29.24% quarter-over-quarter from 0.24 in Q3 2025, and down 33.51% on a YoY basis from 0.25 in Q4 2024.
MediWound (MDWD) Asset Utilization Ratio (2016 - 2025) Analysis & Trends
MediWound's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.17 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 33.51% year-over-year to 0.17; the TTM figure through Dec 2025 stood at 0.17 (down 33.51% YoY), while the FY2025 annual figure was 0.21, down 26.53% from the prior year.
- Asset Utilization Ratio was 0.17 for Q4 2025 at MediWound, down from 0.24 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.74 in Q3 2022 to a low of 0.17 in Q4 2025.
- Historically, Asset Utilization Ratio has averaged 0.43 across 5 years, with a median of 0.37 in 2023.
- The sharpest annual moves came in 2021 and 2023: Asset Utilization Ratio jumped 45.27% in 2021, then slumped 58.24% in 2023.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.69 in 2021, then declined by 8.91% to 0.63 in 2022, then plunged by 58.24% to 0.26 in 2023, then retreated by 3.68% to 0.25 in 2024, then tumbled by 33.51% to 0.17 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.17 (Q4 2025), 0.24 (Q3 2025), and 0.27 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 0.55 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.27 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | 0.25 |
| Sep 30, 2024 | 0.28 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.26 |
| Sep 30, 2023 | 0.36 |
| Jun 30, 2023 | 0.37 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.63 |
| Sep 30, 2022 | 0.74 |
| Jun 30, 2022 | 0.67 |
| Mar 31, 2022 | 0.70 |
| Dec 31, 2021 | 0.69 |
| Sep 30, 2021 | 0.65 |
| Jun 30, 2021 | 0.58 |
| Mar 31, 2021 | 0.53 |